Meyka AI API is live for developers.Start building.
Advertisement
MERCK Kommanditgesellschaft auf Aktien

MERCK Kommanditgesellschaft auf Aktien (MKGAF) Stock Overview

Explore MERCK Kommanditgesellschaft auf Aktien’s financial performance, market position, analyst ratings, and future outlook.

MKGAF●PNK
HealthcareDrug Manufacturers - Specialty & Generic
$158.31
$5.40(3.30%)
U.S. Market opens in 48h 0m
Advertisement

MERCK Kommanditgesellschaft auf Aktien (MKGAF)

Meyka AI Score

Z

Key Financials

Market Cap68.1B
P/E Ratio24.42
EPS (TTM)$6.80
ROE0.08%
Fundamental Analysis

AI Price Forecasts

1 Month$123.14
3 Months$136.54
1 Year Target$129.97

MKGAF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of MERCK Kommanditgesellschaft auf Aktien (MKGAF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 61.33, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $129.97.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 24.42 and a market capitalization of 68.1B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-3.30%
5-Day Change
0.85%
1-Month Change
20.26%
3-Month Change
18.23%
6-Month Change
8.41%
Year-to-Date (YTD) Change
7.26%
1-Year Change
19.25%
3-Year Change
-13.49%
5-Year Change
-11.50%
All-Time (Max) Change
-75.19%

Contact Information

https://www.merckgroup.com/en
49 6151 72 0
Frankfurter Strasse 250, Darmstadt, NaN, 64293

Company Facts

59,020 Employees
IPO DateAug 3, 2012
CountryDE
Actively Trading

Frequently Asked Questions